The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 19, 2025

Filed:

May. 09, 2019
Applicant:

Beijing Innocare Pharma Tech Co., Ltd., Beijing, CN;

Inventors:

Xiangyang Chen, Beijing, CN;

Yucheng Pang, Beijing, CN;

Yingxiang Gao, Jiangsu, CN;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 401/12 (2006.01); A61P 35/00 (2006.01); C07D 413/14 (2006.01);
U.S. Cl.
CPC ...
C07D 401/12 (2013.01); A61P 35/00 (2018.01); C07D 413/14 (2013.01);
Abstract

Disclosed are a new indoline-1-carboxamide compound for regulating or inhibiting the activity of vascular endothelial growth factor receptor (VEGFR), a preparation method therefor, and the medical use thereof. Specifically, the present invention relates to a compound of general formula (I) or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the compound or a pharmaceutically acceptable salt thereof, a method for treating and/or preventing VEGFR-mediated related disorders, especially tumors, using the compound or a pharmaceutically acceptable salt thereof, as well as a method for preparing the compound or a pharmaceutically acceptable salt thereof. The present invention also relates to the use of the compound or a pharmaceutically acceptable salt thereof or the pharmaceutical composition comprising the compound or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for treating and/or preventing VEGFR-mediated related disorders, especially tumors. Each substituent of general formula (I) has the same definition as that in the specification.


Find Patent Forward Citations

Loading…